Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mRNA
Research
Federal mRNA vax grant cuts includes unrelated project
Tiba Biotech's siRNA flu therapeutic was included in the BARDA mRNA vaccine cuts for unclear reasons.
Darren Incorvaia
Aug 7, 2025 2:20pm
Big Pharmas back Strand's $153M series B to advance mRNA drugs
Aug 7, 2025 9:20am
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
BioNTech cuts 90 more US jobs as part of pipeline realignment
Aug 5, 2025 1:24pm
Sanofi inks $1.15B buyout to boost RSV pipeline
Jul 22, 2025 4:20am
AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market
Jun 30, 2025 9:45am
